Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis
- 11 June 2018
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 113 (4) , 28
Abstract
Asymmetric dimethylarginine (ADMA) is a risk factor for heart diseases. Dimethylarginine dimethylaminohydrolase (DDAH) enzymes are key proteins for ADMA degradation. Endothelial DDAH1 is a vital regulator of angiogenesis. DDAH1 is also expressed in cardiomyocytes. However, the role of DDAH1 in cardiomyocytes needs further clarification. Herein, we used an inducible cardiac-specific DDAH1 knockdown mouse (cardiac DDAH1−/−) to investigate the role of cardiomyocyte DDAH1 in left-ventricular (LV) remodeling after acute myocardial infarction (AMI). DDAH1flox/flox and α-MHCMerCreMer mice were used to generate cardiac DDAH1−/− mice. Deletion of DDAH1 in cardiomyocytes was confirmed by Western blotting. No significant differences were observed in plasma ADMA levels and LV function between cardiac DDAH1−/− mice and control mice. Cardiac DDAH1−/− mice showed aggravated LV remodeling 4 weeks after AMI, as demonstrated by a large infarct area and impaired LV function. The rate of cardiomyocyte apoptosis and level of oxidative stress were higher in the LV tissue of cardiac DDAH1−/− mice than in that of control mice. However, treatment of cardiomyocytes with exogenous ADMA had no effect on reactive oxygen species (ROS) levels or apoptosis sensitivity. Cardiac DDAH1−/− LV tissue showed downregulated superoxide dismutase2 (SOD2) expression, and treatment of DDAH1−/− cardiomyocytes with the SOD mimic tempol significantly attenuated apoptosis and ROS levels under hypoxic conditions. Tempol administration also attenuated oxidative stress and apoptosis in cardiac DDAH1−/− LV tissue and partially alleviated LV remodeling after AMI. DDAH1 in cardiomyocytes plays a vital role in attenuating LV remodeling after AMI by regulating intracellular ROS levels and apoptosis sensitivity via a SOD2-dependent pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81770254, 81600308)
This publication has 29 references indexed in Scilit:
- Alginate Oligosaccharide Prevents Acute Doxorubicin Cardiotoxicity by Suppressing Oxidative Stress and Endoplasmic Reticulum-Mediated ApoptosisMarine Drugs, 2016
- Heart Failure, Left Ventricular Remodeling, and Circulating Nitric Oxide MetabolitesJournal of the American Heart Association, 2016
- Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic HomeostasisCirculation, 2015
- Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart FailureStem Cells, 2015
- Cardiovascular remodelling in coronary artery disease and heart failureThe Lancet, 2014
- Tempol prevents cardiac oxidative damage and left ventricular dysfunction in the PPAR-α KO mouseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2013
- Manganese superoxide dismutase: beyond life and deathAmino Acids, 2010
- Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitusDiabetes & Vascular Disease Research, 2010
- Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the CommunityCirculation, 2009
- Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyondAnnals of Medicine, 2006